The role of high mobility group box 1 protein in acute cerebrovascular diseases (Review)
- Authors:
- Shu-Wen Mu
- Yuan Dang
- Shou-Sen Wang
- Jian-Jun Gu
-
Affiliations: Department of Neurosurgery, Dongfang Affiliated Hospital of Xiamen University, Xiamen University Medical College, Fuzhou, Fujian 350025, P.R. China, Department of Comparative Medicine, Dongfang Affiliated Hospital of Xiamen University, Xiamen University Medical College, Fuzhou, Fujian 350025, P.R. China, Department of Neurosurgery, Dongfang Affiliated Hospital of Xiamen University, Xiamen University Medical College, Fuzhou, Fujian 350025, P.R. China, Department of Neuro‑interventional Radiology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan 450000, P.R. China - Published online on: July 10, 2018 https://doi.org/10.3892/br.2018.1127
- Pages: 191-197
-
Copyright: © Mu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Goodwin GH, Sanders C and Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem. 38:14–19. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Sohun M and Shen H: The implication and potential applications of high-mobility group box 1 protein in breast cancer. Ann Transl Med. 4:2172016. View Article : Google Scholar : PubMed/NCBI | |
|
Bertheloot D and Latz E: HMGB1, IL-1α, IL-33 and S100 proteins: Dual-function alarmins. Cell Mol Immunol. 14:43–64. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
George MG, Tong X and Bowman BA: Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol. 74:695–703. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fotakopoulos G, Tsianaka E, Fountas K, Makris D, Spyrou M and Hernesniemi J: Clipping versus coiling in anterior circulation ruptured intracranial aneurysms: A meta-analysis. World Neurosurg. 104:482–488. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ilyas A, Chen CJ, Raper DM, Ding D, Buell T, Mastorakos P and Liu KC: Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: A systematic review. J Neurointerv Surg. 9:1086–1092. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Musumeci D, Roviello GN and Montesarchio D: An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 141:347–357. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Andersson U and Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 29:139–162. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang H, Wang H, Chavan SS and Andersson U: High mobility group box protein 1 (HMGB1): The prototypical endogenous danger molecule. Mol Med. 21 Suppl 1:S6–S12. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Antoine DJ, Harris HE, Andersson U, Tracey KJ and Bianchi ME: A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins. Mol Med. 20:135–137. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Andersson U, Antoine DJ and Tracey KJ: The functions of HMGB1 depend on molecular localization and post-translational modifications. J Intern Med. 276:420–424. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu B, Antoine DJ, Kwan K, Lundbäck P, Wähämaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J, et al: JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci USA. 111:3068–3073. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundbäck P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, et al: Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 488:670–674. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sánchez-Giraldo R, Acosta-Reyes FJ, Malarkey CS, Saperas N, Churchill ME and Campos JL: Two high-mobility group box domains act together to underwind and kink DNA. Acta Crystallogr D Biol Crystallogr. 71:1423–1432. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Martinotti S, Patrone M and Ranzato E: Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther. 4:101–109. 2015.PubMed/NCBI | |
|
Kang R, Zhang Q, Zeh HJ III, Lotze MT and Tang D: HMGB1 in cancer: Good, bad, or both? Clin Cancer Res. 19:4046–4057. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, et al: HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 462:99–103. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Franchi L, Muñoz-Planillo R and Núñez G: Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 13:325–332. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lu B, Wang H, Andersson U and Tracey KJ: Regulation of HMGB1 release by inflammasomes. Protein Cell. 4:163–167. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, Ikushima H, Onoe T, Ohdan H, Yoshida N, et al: Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci USA. 110:20699–20704. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
He SJ, Cheng J, Feng X, Yu Y, Tian L and Huang Q: The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget. 8:64534–64550. 2017.PubMed/NCBI | |
|
van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 11:91–99. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH and Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 101:2652–2660. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Pradere JP, Dapito DH and Schwabe RF: The Yin and Yang of Toll-like receptors in cancer. Oncogene. 33:3485–3495. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xi Y, Shao F, Bai XY, Cai G, Lv Y and Chen X: Changes in the expression of the Toll-like receptor system in the aging rat kidneys. PLoS One. 9:e963512014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang G, Zhang L, Ma L, Jiang R, Kuang G, Li K, Tie H, Wang B, Chen X, Xie T, et al: Glycyrrhetinic acid prevents acetaminophen-induced acute liver injury via the inhibition of CYP2E1 expression and HMGB1-TLR4 signal activation in mice. Int Immunopharmacol. 50:186–193. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, et al: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 8:487–496. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hiraku Y, Guo F, Ma N, Yamada T, Wang S, Kawanishi S and Murata M: Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation. Part Fibre Toxicol. 13:162016. View Article : Google Scholar : PubMed/NCBI | |
|
Das N, Dewan V, Grace PM, Gunn RJ, Tamura R, Tzarum N, Watkins LR, Wilson IA and Yin H: HMGB1 activates proinflammatory signaling via TLR5 leading to allodynia. Cell Reports. 17:1128–1140. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Magna M and Pisetsky DS: The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med. 20:138–146. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Godinho J, de Oliveira RMW, de Sa-Nakanishi AB, Bacarin CC, Huzita CH, Longhini R, Mello JCP, Nakamura CV, Previdelli IS, Dal Molin Ribeiro MH, et al: Ethyl-acetate fraction of Trichilia catigua restores long-term retrograde memory and reduces oxidative stress and inflammation after global cerebral ischemia in rats. Behav Brain Res. 337:173–182. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tsukagawa T, Katsumata R, Fujita M, Yasui K, Akhoon C, Ono K, Dohi K and Aruga T: Elevated serum high-mobility group box-1 protein level Is associated with poor functional outcome in ischemic stroke. J Stroke Cerebrovasc Dis. 26:2404–2411. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S and Moskowitz MA: Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab. 28:927–938. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Shichita T, Sakaguchi R, Suzuki M and Yoshimura A: Post-ischemic inflammation in the brain. Front Immunol. 3:1322012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T, Ohtsuka A, Mori S, et al: Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke. 42:1420–1428. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li WA, Moore-Langston S, Chakraborty T, Rafols JA, Conti AC and Ding Y: Hyperglycemia in stroke and possible treatments. Neurol Res. 35:479–491. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Wu Y, Weng Z, Zhou T, Feng T and Lin Y: Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway. Brain Res. 1582:176–186. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gong G, Xiang L, Yuan L, Hu L, Wu W, Cai L, Yin L and Dong H: Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One. 9:e894502014. View Article : Google Scholar : PubMed/NCBI | |
|
Umahara T, Uchihara T, Hirokawa K, Hirao K, Shimizu S, Hashimoto T, Terasi H and Hanyu H: Time-dependent and lesion-dependent HMGB1-selective localization in brains of patients with cerebrovascular diseases. Histol Histopathol. 33:215–222. 2018.PubMed/NCBI | |
|
Chen JY, Yu Y, Yuan Y, Zhang YJ, Fan XP, Yuan SY, Zhang JC and Yao SL: Enriched housing promotes post-stroke functional recovery through astrocytic HMGB1-IL-6-mediated angiogenesis. Cell Death Discov. 3:170542017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Liu S, Hu Z, Zhu G, Zheng G and Wang G: Enriched housing promotes post-stroke neurogenesis through calpain 1-STAT3/HIF-1α/VEGF signaling. Brain Res Bull. 139133–143. (201841)2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang D, Wu W, Yan H, Jiang T, Liu M, Yu Z, Li H and Hang C: Upregulation of HMGB1 in wall of ruptured and unruptured human cerebral aneurysms: Preliminary results. Neurol Sci. 37:219–226. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ and Dumont AS: Biology of intracranial aneurysms: Role of inflammation. J Cereb Blood Flow Metab. 32:1659–1676. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R and Miyamoto S: Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment. Neurosurgery. 70:1534–1543; discussion 1543. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bianchi ME and Manfredi AA: High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 220:35–46. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Przybycien-Szymanska MM and Ashley WW Jr: Biomarker discovery in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 24:1453–1464. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chang CZ, Wu SC, Kwan AL and Lin CL: Rhinacanthin-C, A fat-soluble extract from Rhinacanthus nasutus, modulates high-mobility group box 1-related neuro-inflammation and subarachnoid hemorrhage-induced brain apoptosis in a rat model. World Neurosurg. 86:349–360. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao XD, Mao HY, Lv J and Lu XJ: Expression of high-mobility group box-1 (HMGB1) in the basilar artery after experimental subarachnoid hemorrhage. J Clin Neurosci. 27:161–165. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Wu W, Sun Q, Liu M, Li W, Zhang XS, Zhou ML and Hang CH: Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage. Brain Res. 1543:315–323. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang XS, Li W, Wu Q, Wu LY, Ye ZN, Liu JP, Zhuang Z, Zhou ML, Zhang X and Hang CH: Resveratrol attenuates acute inflammatory injury in experimental subarachnoid hemorrhage in rats via inhibition of TLR4 pathway. Int J Mol Sci. 17:172016. | |
|
Hendrix P, Foreman PM, Harrigan MR, Fisher WSR III, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, et al: Impact of high-mobility group box 1 polymorphism on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. World Neurosurg. 101:325–330. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tian X, Sun L, Feng D, Sun Q, Dou Y, Liu C, Zhou F, Li H, Shen H, Wang Z, et al: HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage. Brain Res. 1670:135–145. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qureshi AI, Mendelow AD and Hanley DF: Intracerebral haemorrhage. Lancet. 373:1632–1644. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lei C, Wu B, Cao T, Zhang S and Liu M: Activation of the high-mobility group box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage. Stroke. 46:500–506. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YX, Yan A, Ma ZH, Wang Z, Zhang B, Ping JL, Zhu JS, Zhou Y and Dai L: Nuclear factor-κB and apoptosis in patients with intracerebral hemorrhage. J Clin Neurosci. 18:1392–1395. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lei C, Zhang S, Cao T, Tao W, Liu M and Wu B: HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage. Neuroscience. 295:39–47. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Lei C, Zhang S, Zhang S, Liu M and Wu B: Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Neurosci Lett. 609:109–119. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Liu K, Wake H, Teshigawara K, Mori S and Nishibori M: Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats. Sci Rep. 7:462432017. View Article : Google Scholar : PubMed/NCBI | |
|
Shang J, Deguchi K, Ohta Y, Liu N, Zhang X, Tian F, Yamashita T, Ikeda Y, Matsuura T, Funakoshi H, et al: Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res. 89:86–95. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma KM and Ahn J: Cerebral venous sinus thrombophlebitis as a complication of acute otitis media. J Emerg Med. 48:e9–e13. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gu JJ, Chen JB, Zhang JH, Zhang H and Wang SS: Recombinant human soluble thrombomodulin protects against brain injury in a CVST rat model, via downregulation of the HMGB1-RAGE axis. Mol Med Rep. 14:5217–5222. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Nagai M, Terao S, Yilmaz G, Yilmaz CE, Esmon CT, Watanabe E and Granger DN: Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis. Stroke. 41:147–152. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yang H, Meng Z, Zhang C, Zhang P and Wang Q: Establishing a new rat model of central venous sinus thrombosis and analyzing its pathophysiological and apoptotic changes. J Neurosci Methods. 203:130–135. 2012. View Article : Google Scholar : PubMed/NCBI |
